2m 2m 2m 2m 2m 2m 2m
TG Therap (TGTX)
NASDAQ
$53.95-$0.45 (-0.83%)
Price as of Jun 23, 2026 6:36 PM EDT- $8.3BMarket Cap
- 48.80%1-Year Change
- BiotechnologyIndustry
TG Therap (TGTX)
$53.95-$0.45 (-0.83%)
TGTX | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $54.40 | ||
Change | +$1.18 (+2.22%) | ||
Open | $54.61 | ||
High | $57.38 | ||
Low | $54.24 | ||
Previous Close | $53.22 | ||
Volume | 3,979,231 | ||
30-Day Average Volume | 2,619,669 | ||
1-Week Change | 8.15% | ||
1-Month Change | 39.95% | ||
1-Year Change | 48.80% | ||
3-Year Change | 129.44% | ||
5-Year Change | 44.91% | ||
Fundamentals | |||
Shares Outstanding | 153.1M | ||
Total Assets | $1.5B | ||
Market Cap | $8.3B | ||
Enterprise Value | $8.6B | ||
Period: QTR TTM FY | |||
Revenue | $201.3M | ||
Net Income | $19.8M | ||
Free Cash Flow | -$17.9M | ||
EBIT | $20.4M | ||
EBITDA | $20.4M | ||
Net Working Capital | $899.9M | ||
EPS | $0.12 | ||
Enterprise Value/EBITDA | 423 | ||
Enterprise Value/Revenue | 43 | ||
P/B | 14 | ||
P/E | 453 | ||
PEG | -27 | ||
Price/Free Cash Flow | -464 | ||
Price/Operating Cash Flow | -465 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 56.25 | ||
Last Split Date | 04/30/2012 | ||
Earnings & Revenue